Amengual Jaume, García-Carrizo Francisco J, Arreguín Andrea, Mušinović Hana, Granados Nuria, Palou Andreu, Bonet M Luisa, Ribot Joan
Grup de Recerca Nutrigenòmica i Obesitat, Laboratori de Biologia Molecular, Nutrició i Biotecnologia (LBNB), Universitat de les Illes Balears, Palma de Mallorca, Spain.
Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Cell Physiol Biochem. 2018;46(1):187-202. doi: 10.1159/000488422. Epub 2018 Mar 21.
BACKGROUND/AIMS: All-trans retinoic acid (ATRA) has protective effects against obesity and metabolic syndrome. We here aimed to gain further insight into the interaction of ATRA with skeletal muscle metabolism and secretory activity as important players in metabolic health.
Cultured murine C2C12 myocytes were used to study direct effects of ATRA on cellular fatty acid oxidation (FAO) rate (using radioactively-labelled palmitate), glucose uptake (using radioactively-labelled 2-deoxy-D-glucose), triacylglycerol levels (by an enzymatic method), and the expression of genes related to FAO and glucose utilization (by RT-real time PCR). We also studied selected myokine production (using ELISA and immunohistochemistry) in ATRA-treated myocytes and intact mice.
Exposure of C2C12 myocytes to ATRA led to increased fatty acid consumption and decreased cellular triacylglycerol levels without affecting glucose uptake, and induced the expression of the myokine irisin at the mRNA and secreted protein level in a dose-response manner. ATRA stimulatory effects on FAO-related genes and the Fndc5 gene (encoding irisin) were reproduced by agonists of peroxisome proliferator-activated receptor β/δ and retinoid X receptors, but not of retinoic acid receptors, and were partially blocked by an AMP-dependent protein kinase inhibitor. Circulating irisin levels were increased by 5-fold in ATRA-treated mice, linked to increased Fndc5 transcription in liver and adipose tissues, rather than skeletal muscle. Immunohistochemistry analysis of FNDC5 suggested that ATRA treatment enhances the release of FNDC5/irisin from skeletal muscle and the liver and its accumulation in interscapular brown and inguinal white adipose depots.
These results provide new mechanistic insights on how ATRA globally stimulates FAO and enhances irisin secretion, thereby contributing to leaning effects and improved metabolic status.
背景/目的:全反式维甲酸(ATRA)对肥胖和代谢综合征具有保护作用。我们旨在进一步深入了解ATRA与骨骼肌代谢及分泌活性之间的相互作用,而骨骼肌代谢及分泌活性是代谢健康的重要因素。
使用培养的小鼠C2C12肌细胞来研究ATRA对细胞脂肪酸氧化(FAO)速率(使用放射性标记的棕榈酸)、葡萄糖摄取(使用放射性标记的2-脱氧-D-葡萄糖)、三酰甘油水平(通过酶法)以及与FAO和葡萄糖利用相关基因的表达(通过RT-实时PCR)的直接影响。我们还研究了经ATRA处理的肌细胞和完整小鼠中选定的肌动蛋白生成情况(使用ELISA和免疫组织化学)。
将C2C12肌细胞暴露于ATRA会导致脂肪酸消耗增加和细胞三酰甘油水平降低,而不影响葡萄糖摄取,并以剂量反应方式在mRNA和分泌蛋白水平诱导肌动蛋白鸢尾素的表达。过氧化物酶体增殖物激活受体β/δ和视黄酸X受体的激动剂可重现ATRA对FAO相关基因和Fndc5基因(编码鸢尾素)的刺激作用,但视黄酸受体的激动剂则不能,且该作用被AMP依赖性蛋白激酶抑制剂部分阻断。在经ATRA处理过的小鼠中,循环鸢尾素水平增加了5倍,这与肝脏和脂肪组织中Fndc5转录增加有关,而非骨骼肌。FNDC5的免疫组织化学分析表明,ATRA处理可增强FNDC5/鸢尾素从骨骼肌和肝脏的释放及其在肩胛间棕色和腹股沟白色脂肪库中的积累。
这些结果为ATRA如何全面刺激FAO并增强鸢尾素分泌提供了新的机制性见解,从而有助于产生瘦身效果并改善代谢状态。